| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 01/01/2019 | 3. Issuer Name and Ticker or Trading Symbol Nightstar Therapeutics plc [ NITE ] | |||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) 01/02/2019 | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Ordinary Shares(1) | 43,690(2) | D | |
| Ordinary Shares(1) | 25,430(3) | D | |
| Ordinary Shares(1) | 16,953(4) | D | |
| Ordinary Shares(1) | 19,073(5) | D | |
| Ordinary Shares(1) | 13,635(6) | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Option (Right to Buy) | (7) | 01/30/2028 | Ordinary Shares(1) | 75,000 | 14.24 | D | |
| Explanation of Responses: |
| 1. The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer. |
| 2. On January 2, 2019, a Form 3 was filed to report the equity holdings of the Reporting Person. The report provided by the Issuer's equity administrator contained errors relating to the Reporting Person's holdings which have been corrected herein. This Form 3/A amends and restates, in its entirety, the original Form 3. |
| 3. Represent unvested restricted share awards granted on October 3, 2016. Shares shall vest on a pro rata quarterly basis through July 1, 2020. |
| 4. Represent unvested restricted share awards granted on October 3, 2016. Shares shall vest on a pro rata quarterly basis through January 1, 2021. |
| 5. Represent unvested restricted share awards granted on October 3, 2016. Shares shall vest on a pro rata quarterly basis through April 1, 2021. |
| 6. Represent unvested restricted share awards granted on August 23, 2017. Shares shall vest on a pro rata quarterly basis through July 1, 2021. |
| 7. 25% vested as of January 1, 2019. The remainder of the underlying shares will vest in in 36 equal monthly installments thereafter. |
| Remarks: |
| Exhibit List: Exhibit 24.1 - Power of Attorney |
| /s/ Bryan Yoon, Attorney-in-Fact | 01/09/2019 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
